In June 2023, Uresa A. (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune ...
Jul 8, 2024
0
44
Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to a tumor-suppressing gene called VHL, the first step in a huge research endeavor to unpick the outcomes of tens of thousands of ...
Jul 5, 2024
0
22
Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first, the cancer comes back.
Jul 1, 2024
0
46
A loss of salt and body fluid can stimulate kidney regeneration and repair in mice, according to a new study led by USC Stem Cell scientist Janos Peti-Peterdi and published in the Journal of Clinical Investigation.
Jun 28, 2024
0
73
Immune system cells called macrophages play an unexpected role in the complicated connection between obesity and cancer, a Vanderbilt University Medical Center-led research team has discovered.
Jun 12, 2024
0
24
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center's Kidney Cancer Program sheds light. Published ...
Jun 12, 2024
0
15
Red and yellow and pink and green—your urine can sing a rainbow too. You may be surprised to find out it can be purple and orange and blue. And a myriad of other unusual colors besides.
Jun 10, 2024
0
2
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
0
In a first-of-its-kind study, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) report that even lead levels below the EPA's threshold in household water may adversely affect individuals with chronic kidney ...
May 30, 2024
1
37
Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team has developed a new method to predict which patients will benefit from it. The team of Francesca Finotello (Computational ...
May 24, 2024
0
6
